Prevalence and frequency of circulating t (14; 18)‐MBR translocation carrying cells in healthy individuals

F Schüler, L Dölken, C Hirt, T Kiefer… - … journal of cancer, 2009 - Wiley Online Library
F Schüler, L Dölken, C Hirt, T Kiefer, T Berg, G Fusch, K Weitmann, W Hoffmann, C Fusch…
International journal of cancer, 2009Wiley Online Library
Abstract The t (14; 18) translocation is a common genetic aberration that can be seen as an
early step in pathogenesis of follicular lymphoma (FL). The significance of low level
circulating t (14; 18)‐positive cells in healthy individuals as clonal lymphoma precursors or
indicators of risk is still unclear. We determined the age dependent prevalence and
frequency of BCL2/IgH rearrangements in 715 healthy individuals ranging from newborns to
octo‐and nonagenarians. These results were compared with number of circulating t (14; 18) …
Abstract
The t(14;18) translocation is a common genetic aberration that can be seen as an early step in pathogenesis of follicular lymphoma (FL). The significance of low level circulating t(14;18)‐positive cells in healthy individuals as clonal lymphoma precursors or indicators of risk is still unclear. We determined the age dependent prevalence and frequency of BCL2/IgH rearrangements in 715 healthy individuals ranging from newborns to octo‐ and nonagenarians. These results were compared with number of circulating t(14;18)‐positive cells in 108 FL patients at initial presentation. The overall prevalence of BCL2/IgH junctions in this large sample was 46% (327/715). However, there was a striking dependence upon age. Specifically, among individuals up to 10 years old, none had detectable circulating t(14;18)‐positive cells. In the age groups representing 10–50 years old, we found a steady elevation in the prevalence of BCL2/IgH junctions up to a prevalence of 66%. Further increases of the prevalence in individuals older than 50 years were not seen. The mean frequency of BCL2/IgH junctions in healthy individuals ≥40 years (18–26 × 10−6) was significantly higher than in younger subjects (7–9 × 10−6). Four percent (31/715) of individuals carried more than one t(14;18)‐positive cell per 25,000 peripheral blood mononuclear cells (PBMNCs). In comparison, 108 stage III/IV FL patients had a median number of circulating t(14;18)‐positive malignant FL cells of about 9200/1 million PBMNCs (range 7–1,000,000). These findings will further improve the understanding of the relevance of t(14;18)‐positive cells in healthy individuals as a risk marker toward the development into lymphoma precursors. © 2008 Wiley‐Liss, Inc.
Wiley Online Library